Bank of Nova Scotia’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,364	Closed	-$811K	–	1273
2022 Q3	$811K	Buy	5,364 +487	+10%	+$73.6K	﹤0.01%	841
2022 Q2	$711K	Sell	4,877 -422	-8%	-$61.5K	﹤0.01%	916
2022 Q1	$628K	Sell	5,299 -2,676	-34%	-$317K	﹤0.01%	1000
2021 Q4	$1.11M	Buy	+7,975	New	+$1.11M	﹤0.01%	927